|
GB9606452D0
(en)
*
|
1996-03-27 |
1996-06-05 |
Sandoz Ltd |
Organic compounds
|
|
ES2182112T3
(es)
|
1996-07-30 |
2003-03-01 |
Novartis Ag |
Composiciones farmaceuticas para el tratamiento del rechazo de transplantes y de estados autoinmunes o inflamatorios, que comprenden ciclosporina a y 40-o-(2-hidroxietil)-rapamicina.
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US20030129215A1
(en)
*
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
|
EP1980263A1
(en)
*
|
1999-05-10 |
2008-10-15 |
Novartis AG |
Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
|
|
US6790228B2
(en)
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
US20070032853A1
(en)
|
2002-03-27 |
2007-02-08 |
Hossainy Syed F |
40-O-(2-hydroxy)ethyl-rapamycin coated stent
|
|
US7807211B2
(en)
|
1999-09-03 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of an implantable medical device
|
|
US20070141107A1
(en)
*
|
2000-03-15 |
2007-06-21 |
Orbusneich Medical, Inc. |
Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
|
|
EP1263484B1
(en)
|
2000-03-15 |
2007-05-16 |
OrbusNeich Medical, Inc. |
Coating which promotes endothelial cell adherence
|
|
US8460367B2
(en)
*
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US20030229393A1
(en)
*
|
2001-03-15 |
2003-12-11 |
Kutryk Michael J. B. |
Medical device with coating that promotes cell adherence and differentiation
|
|
US20070055367A1
(en)
*
|
2000-03-15 |
2007-03-08 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
|
US20050002986A1
(en)
*
|
2000-05-12 |
2005-01-06 |
Robert Falotico |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US7300662B2
(en)
|
2000-05-12 |
2007-11-27 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
EP1709974A3
(en)
*
|
2000-06-16 |
2006-12-06 |
Wyeth |
Method of treating cardiovascular disease using rapamycin
|
|
US6670355B2
(en)
*
|
2000-06-16 |
2003-12-30 |
Wyeth |
Method of treating cardiovascular disease
|
|
US20020013335A1
(en)
*
|
2000-06-16 |
2002-01-31 |
American Home Products Corporation |
Method of treating cardiovascular disease
|
|
AU2001294869B2
(en)
|
2000-09-29 |
2006-06-15 |
Cardinal Health 529, Llc |
Coated medical devices
|
|
LT3143995T
(lt)
*
|
2001-02-19 |
2019-01-25 |
Novartis Ag |
Rapamicino darinys, skirtas plaučių vėžio gydymui
|
|
US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
|
US7682387B2
(en)
*
|
2002-04-24 |
2010-03-23 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
US6939376B2
(en)
*
|
2001-11-05 |
2005-09-06 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
NZ535199A
(en)
*
|
2002-02-22 |
2006-03-31 |
Prophy Med Ab |
Use of an inhibitor or antagonist against tissue factor
|
|
US20040024450A1
(en)
*
|
2002-04-24 |
2004-02-05 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
KR20050010827A
(ko)
*
|
2002-05-20 |
2005-01-28 |
오르버스 메디칼 테크놀로지즈 인코포레이티드 |
약물 용리 이식성 의료 장치
|
|
US8109987B2
(en)
|
2003-04-14 |
2012-02-07 |
Tryton Medical, Inc. |
Method of treating a lumenal bifurcation
|
|
US7279174B2
(en)
*
|
2003-05-08 |
2007-10-09 |
Advanced Cardiovascular Systems, Inc. |
Stent coatings comprising hydrophilic additives
|
|
US20050118344A1
(en)
|
2003-12-01 |
2005-06-02 |
Pacetti Stephen D. |
Temperature controlled crimping
|
|
US7220755B2
(en)
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
|
KR20070008714A
(ko)
*
|
2004-04-30 |
2007-01-17 |
오르버스네이치 메디칼 인코포레이티드 |
유전적으로-변형된 세포 포획용 코팅을 갖는 의료 장치 및이의 사용 방법
|
|
EP1768662A2
(en)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
US7901451B2
(en)
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
WO2006069038A1
(en)
*
|
2004-12-20 |
2006-06-29 |
Ariad Gene Therapeutics, Inc. |
Therapeutic materials and methods
|
|
EP2662082A1
(en)
|
2005-11-14 |
2013-11-13 |
Ariad Pharmaceuticals, Incorporated |
Administration of mTOR inhibitors
|
|
WO2007058399A1
(en)
*
|
2005-11-17 |
2007-05-24 |
Access Plus Co., Ltd |
A tube for connecting marteriovenous and interposition for medical operation
|
|
US20070173923A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Savage Douglas R |
Drug reservoir stent
|
|
CN101557814B
(zh)
|
2006-09-13 |
2015-05-20 |
万能医药公司 |
大环内酯化合物及它们的使用方法
|
|
US20080097591A1
(en)
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
|
US20080103584A1
(en)
*
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
|
KR100930167B1
(ko)
*
|
2007-09-19 |
2009-12-07 |
삼성전기주식회사 |
초광각 광학계
|
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
|
WO2009065087A1
(en)
|
2007-11-14 |
2009-05-22 |
Biosensors International Group, Ltd. |
Automated coating apparatus and method
|
|
US8921642B2
(en)
*
|
2008-01-11 |
2014-12-30 |
Massachusetts Eye And Ear Infirmary |
Conditional-stop dimerizable caspase transgenic animals
|
|
CN102231969A
(zh)
*
|
2008-10-03 |
2011-11-02 |
万能医药公司 |
大环内酯化合物及其使用方法
|
|
US8382818B2
(en)
|
2009-07-02 |
2013-02-26 |
Tryton Medical, Inc. |
Ostium support for treating vascular bifurcations
|
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
|
UA104738C2
(ru)
|
2011-05-18 |
2014-03-11 |
Олег Миколайович Лазаренко |
Композиция для повышения биосовместимости имплантатов и клеток для трансплантации с организмом реципиента и способ ее приготовления
|
|
CN102268015B
(zh)
*
|
2011-08-30 |
2013-08-28 |
成都摩尔生物医药有限公司 |
一种依维莫司的合成方法
|
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
|
KR101723265B1
(ko)
|
2013-08-16 |
2017-04-04 |
가톨릭대학교 산학협력단 |
mTOR/STAT3 신호억제제 처리된 면역조절능을 갖는 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
|
|
CN105792775B
(zh)
|
2013-09-24 |
2019-02-19 |
吉纳生命科学公司 |
用于细胞植入物的气体处理的系统
|
|
EP3738592B1
(en)
|
2013-10-08 |
2022-01-26 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
US10307371B2
(en)
|
2014-02-11 |
2019-06-04 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
EP3104891A1
(en)
|
2014-02-11 |
2016-12-21 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
CA2944075C
(en)
|
2014-04-04 |
2022-06-28 |
Lam Therapeutics, Inc. |
An inhalable rapamycin formulation for treating age-related conditions
|
|
CA2963085C
(en)
|
2014-10-07 |
2023-02-21 |
Lam Therapeutics, Inc. |
An inhalable rapamycin formulation for the treatment of pulmonary hypertension
|
|
MA40910A
(fr)
|
2014-11-07 |
2017-09-12 |
Civitas Therapeutics Inc |
Poudres de rapamycine pour administration pulmonaire
|
|
WO2016130645A1
(en)
|
2015-02-10 |
2016-08-18 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
JP2019527711A
(ja)
|
2016-08-10 |
2019-10-03 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
局所ラパマイシン療法
|
|
WO2018050916A1
(en)
|
2016-09-19 |
2018-03-22 |
Biotronik Ag |
Polymer-free drug eluting vascular stents
|
|
WO2018093956A1
(en)
|
2016-11-15 |
2018-05-24 |
Giner, Inc. |
Percutaneous gas diffusion device suitable for use with a subcutaneous implant
|
|
EP3558407B1
(en)
|
2016-12-22 |
2023-03-15 |
Biotronik AG |
Drug releasing coatings for medical devices and methods of making same
|
|
CN110831656A
(zh)
|
2017-05-04 |
2020-02-21 |
吉纳生命科学公司 |
稳健的可植入气体递送装置和方法、系统以及包括该装置的装置
|
|
UY37900A
(es)
|
2017-09-26 |
2019-04-30 |
Novartis Ag |
Nuevos derivados de rapamicina
|
|
MX2021007247A
(es)
|
2018-12-18 |
2021-07-15 |
Novartis Ag |
Derivados de rapamicina.
|
|
CN113710232A
(zh)
|
2019-02-20 |
2021-11-26 |
人工智能治疗公司 |
局部雷帕霉素制剂及其在治疗面部血管纤维瘤和其他皮肤病中的用途
|